Effects of Intravitreal Ranibizumab in the Treatment of Retinopathy of Prematurity in Chinese Infants

Abstract

Intravitreal ranibizumab is effective for the treatment of retinopathy of prematurity, although a small amount of patients recurred. Compared with intravitreal bevacizumab, a higher incidence and shorter time to recurrence were observed after intravitreal ranibizumab treatment, thus longer and more frequent follow-ups are needed.